Japanese eye drug specialist Santen Pharmaceutical said on February 7 that it will fully resume operations by the end of March at its manufacturing plant damaged by a massive earthquake that struck the Noto Peninsula on New Year’s Day.
Production lines at the company’s Noto Plant in the central Japan prefecture of Ishikawa will be gradually brought back online from March, with full operations to be restored before the end of the month, it said.
Shipments from the plant have already restarted since late January. On January 11, it placed a shipment restriction on the glaucoma and ocular hypertension drug Cosopt Mini (dorzolamide + timolol), but no other products are affected by such measures.
